ATF5 and cancer: PRMT1 promotes cell survival through epigenetic activation of the prosurvival factor ATF5, thus providing a new mechanistic link between overexpression of PRMT1 and compromised apoptotic pathway, a malignant phenotype characteristic of a large number of cancers, including neuroblastoma.